Table 1.
Characteristics | NRT (n = 25) | IVT (n = 27) | EVT (n = 18) | F/Z/χ2 | P value |
---|---|---|---|---|---|
Age, mean ± SD, years | 75.16 ± 7.60 | 79.41 ± 7.36 | 67.61 ± 11.43 | 12.42a | <0.01 |
Male (%) | 13 (52) | 12 (44.44) | 11 (61.11) | 1.21b | 0.547 |
Left hemisphere (%) | 17 (68) | 15 (55.56) | 13 (72.22) | 1.54b | 0.463 |
rLMCs, median (IQR) | 15 (12, 17) | 17 (14.7, 19) | 16 (14, 18) | 4.76a | 0.105 |
Admission NIHSS score, median (IQR) | 12 (7.5, 20.5) | 11 (9, 15) | 14 (9, 17.5) | 2.42a | 0.298 |
Admission NIHSS score stratification (%) | |||||
<13 | 13 (52) | 18 (66.67) | 8 (44.44) | 4.70c | 0.095 |
13-19 | 5 (20) | 9 (33.33) | 9 (50) | ||
≥ 20 | 7 (28) | 0 | 1 (5.56) | ||
Vascular risk factors | |||||
Hypertension (%) | 15 (60) | 11 (40.74) | 5 (27.78) | 4.63b | 0.099 |
Diabetes (%) | 4 (16) | 6 (22.22) | 5 (27.78) | 0.88b | 0.644 |
Hyperlipidemia (%) | 8 (32) | 3 (11.11) | 7 (38.89) | 5.17b | 0.076 |
Coronary heart disease (%) | 3 (12) | 8 (29.63) | 4 (22.22) | 2.41b | 0.30 |
Congestive heart failure (%) | 5 (20) | 2 (7.41) | 5 (27.78) | 3.47d | 0.171 |
Atrial fibrillation (%) | 8 (32) | 8 (29.63) | 10 (55.56) | 3.55b | 0.186 |
History of ischemic stroke (%) | 4 (16) | 4 (14.81) | 1 (5.56) | 1.13d | 0.668 |
Drinking (%) | 1 (4) | 2 (7.41) | 3 (16.67) | 2.08d | 0.428 |
Smoking (%) | 4 (16) | 3 (11.11) | 6 (33.33) | 3.42d | 0.166 |
Antiplatelet drugs are currently used (%) | 1 (4) | 0 | 3 (16.67) | 4.62d | 0.059 |
Statins are currently used (%) | 1 (4) | 0 | 3 (16.67) | 4.62d | 0.059 |
Admission serum glucose level, mean ± SD, mmol/l | 8.06 ± 4.72 | 7.58 ± 2.39 | 7.71 ± 2.43 | 0.42a | 0.81 |
Admission systolic blood pressure, mean ± SD, mmHg | 156.8 ± 25.7 | 154 ± 22.06 | 142.67 ± 18.77 | 2.19e | 0.12 |
Hospitalization days, mean ± SD | 13.04 ± 4.95 | 11.70 ± 5.04 | 11.06 ± 4.54 | 0.95e | 0.39 |
Time from onset to treatment, median (IQR), min | 370 (230.5, 820.5) | 154 (125.0, 238.0) | 272.5 (183.8, 386.3) | 20.80a | <0.01 |
Abbreviations: NRT: no reperfusion therapy; IVT: intravenous thrombolysis treatment; EVT: endovascular intervention; rLMCs: regional leptomeningeal score; NIHSS: National Institutes of Health Stroke Scale; SD: standard deviation; IQR: interquartile range. aKruskal-Wallis test; bχ2 test; crank sum test; dFisher's exact probability method; eANOVA.